Sienna Biopharmaceuticals Appoints John W. Smither as Chief Financial Officer

Author's Avatar
Mar 21, 2018
Article's Main Image

WESTLAKE VILLAGE, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced the appointment of John W. Smither as the Company’s Chief Financial Officer. Mr. Smither will succeed Richard Peterson, who has resigned for personal reasons, effective Mar. 29, 2018.